MGUS/MM Awareness And Genetic Insights Campaign (MAGIC)

Overview

About this study

This proposal will determine the prevalence of MGUS among people of East African descent to improve the role of ancestral genetic diversity in myeloma research, allow an opportunity for early intervention, and reduce the disparity in diagnosing and monitoring precursor conditions for an incurable cancer which disproportionately affects those of African descent.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adults ≥ 40 years without a diagnosis of Multiple Myeloma.
Self-reported East African ancestry (including individuals of mixed East African descent).

Exclusion Criteria:

Known diagnosis of multiple myeloma.
Pregnant women.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/3/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Joselle Cook, M.B.B.S.	Open for enrollment	Contact information: Sarah Aug 5075381301 aug.sarah@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joselle Cook, M.B.B.S.

Open for enrollment

Contact information:

Sarah Aug

5075381301

aug.sarah@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials